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Accepted 12 March 2012AbstractObjective: Previously, we found that altered sialidases in HeLa cells in a natural killer-HeLa (NK-HeLa) coculture system contributed to the
decreased cytotoxic ability of NK cells. However, changes that occur in the glycosylation of the HeLa cells in the NK-HeLa coculture system
remain unknown.
Materials and Methods: An NK-HeLa coculture system was used to examine the changes that occur in the gangliosides of HeLa cells.
Results: GD3 expression in HeLa cells was significantly increased in the NK-HeLa coculture system. Exogenous ganglioside GD3 decreased the
cytotoxic ability of the NK cells, which could be restored by the addition of the anti-GD3 antibody. Coadministration of GD3 and sialidase
further decreased the cytotoxic ability of the NK cells, which could be partially restored by the addition of a sialidase inhibitor (DANA). GD3
expression in HeLa cells also decreased following DANA treatment.
Conclusions: This study suggests that interactions between ganglioside GD3 and sialidases in HeLa cells influence the cytotoxic ability of NK
cells.
Copyright  2012, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Cervical cancer is the second most common malignancy
that presents in women worldwide [1], and some studies have
reported that immune cell function is influenced by cancer
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doi:10.1016/j.tjog.2012.04.006viral infection in cervical tissues and are a key component in
tumor immunosurveillance [5]. However, a lot of data indi-
cates that NK cell cytotoxicity is downregulated during cancer
development, including cervical carcinoma [6e9].
GD3 ganglioside, a glycosphingolipid that contains one or
more sialic acid (SA) residues, is markedly overexpressed in
almost all melanoma tissues and plays a role in the growth of
malignant cells [10]. It has been proposed that GD3 ganglio-
side could possibly inhibit the immune response in humans
[11, 12] and that the addition of the GD3 monoclonal antibody
(R24) to NK cells could promote antibody-dependent cellular
cytotoxicity (ADCC), thereby resulting in tumor shrinkage in
cancer patients [13,14].cs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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be involved in cellular interactions, communication, and
possibly immune responses [15,16]. SA is almost always
present on the glycoproteins and glycolipids that are widely
distributed throughout nature [17]. Aberrant sialylation is
closely associated with the malignant phenotype of cancer
cells, including metastatic potential and invasiveness [18].
Sialidases (neuraminidase) influence cellular activity by
removing terminal SA residues from glycoproteins and
glycolipids. Four genetically distinct sialidases have been
identified in mammalian cells, each with a predominant
cellular localization [19,20]. Neu1 (the lysosomal form) plays
a catabolic role in desialylating glycoproteins and is involved
in the cellular signaling of immune responses. Neu2 (the
cytosolic form) can desialylate glycoproteins and gangliosides
and appears to play a role in myoblast differentiation. Neu3
(the plasma membranous form) plays a regulatory role in
cellular activation, differentiation, and transformation. Neu4
(the lysosomal or mitochondrial form) has been identified and
may be involved in cell apoptosis. It is well known that the
expression levels of sialidases are related to cancer progres-
sion [21,22]. In addition, the enzymatic removal of all SA
residues from NK cells by sialidase (neuraminidase) impairs
the immune functions of NK cells [23,24]. In a previous study,
we found that expression of sialidases, especially Neu2 and
Neu3 in HeLa cells, is increased in an NK-HeLa coculture
system [25]. However, the gangliosides that change in HeLa
cells in this NK-HeLa coculture system are uncertain.
Materials and methodsCell linesThe human cervical cancer cell linesdCC7T, CaSki, and
HeLadand the NK-sensitive cell linedK562dwere obtained
from the Culture Collection and Research Center, Food Industry
and Development Institute (Hsin-Chu, Taiwan). CC7T cells and
HeLa cells were grown in DMEM (Gibco, GibcoBRL, Grand
Island, NY, USA) and supplemented with 10% fetal bovine
serum (FBS) and 1%penicillin-streptomycin (PS; 10,000U/mL;
Gibco). CaSki cells and K562 cells were grown in RPMI1640
medium (Gibco) and supplemented with 10% FBS and 1% PS.
All cell types were cultured in 10-cm dishes at 37C in
a humidified atmosphere with 5% CO2.NK cellsPeripheral blood mononuclear cells (PBMCs) were sepa-
rated from leukapheresed adult peripheral blood by
Ficoll-Hypaque density gradient centrifugation (Amersham
Biosciences, GE Healthcare Life Sciences. Piscataway, NJ,
USA) [26]. PBMCs were resuspended at a concentration of
106 cells/mL and cultured for 18 days. Then, NK cells were
isolated from the PBMCs by auto-MACS (NK Isolation Kit;
Miltenyi Biotec, Germany) and cultured for 1 day. PBMCs and
NK cells were maintained in RPMI 1640 medium supple-
mented with 10% FBS, 1% PS, and 1000 U/mL recombinanthuman interleukin (IL)-2 (PeproTech Asia, Israel) at 37C in
a humidified atmosphere with 5% CO2.Interactions between NK and HeLa cellsUsing the same procedure as a previous study [25], the
interactions between NK and HeLa cells were analyzed using
a constant number of NK cells, which were directly cultured
with HeLa cells (in a 1:1 ratio) in RPMI 1640 medium that had
been supplemented with 10% FBS, 1% PS, and 1000 U/mL
IL-2 for 3.5 hours at 37C in an atmosphere that contained 5%
CO2. In the sialidase inhibition experiment, the cocultured
cells were treated with or without the sialidase inhibitor
DANA (sodium 5-Acetamido-2,6-anhydro-2,3-dehydro-3,5-
dideoxy-D-glycero-D-galactononanoate; Calbiochem,
MERCK, Darmstadt, Germany).NK cell cytotoxicity assay2106 K562 cells were incubate with 100 mCi of 51Cr in
1mL RPMI1640 medium at 37C for 60 minutes, and then
centrifuged at 3000g to remove the supernatant. The K562
cells were washed by RPMI1640 medium then centrifuged at
3000g to remove supernatant. These radiolabeled target cells
were seeded onto round-bottom 96-well microplates ontowhich
the NK cells, NK/CC7T, NK/CaSki, or NK/HeLa cells were
cultured (NK:target ratio of 2:1, 1:1, and 0.5:1, respectively) and
incubated for 3 hours at 37C in an atmosphere that contained
5% CO2. Supernatants containing the
51Cr that was released
from the lysed target cells were collected, and the radioactivity
was counted using a Packard gamma counter (PerkinElmer Inc.,
United States). All experiments were repeated at least three
times. The percentage of specific lysis was calculated according
to the following formula: (sample 51Cr releasede spontaneously
released)  100/(maximum amount released e amount spon-
taneously released)  100 [27].Flow cytometric analysisMousemonoclonal anti-humanGD3 antibody (R24; Abcam,
Abcam Ltd, Cambridge, UK) was labeled with fluorescein
isothiocyanate (FITC) using the E-Z FITC labeling kit (Pierce,
Rockford, IL USA), according to the manufacturer’s directions.
The FITC-conjugated monoclonal anti-human CD56 antibody,
isotype control, and propidium iodidewere purchased fromBio-
legend (Bio-legend, San Diego, CA, USA).
To detect GD3 expression in the HeLa cells, the cells were
incubated with FITC-labeled anti-human GD3 antibody or the
isotype control antibody for 30 minutes at 4C. After washing
with PBS, the cells were analyzed using an FACSort flow
cytometer (BD Biosciences, California, USA). To determine
the viability of the NK cells, the cells were incubated with
FITC-labeled anti-human CD56 antibody for 30 minutes at
4C, followed by a PBS wash, and then propidium iodide was
added to exclude the dead cells. Data analysis was performed
using BD CELLQuest software (BD Biosciences, California,
USA).
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in RPMI 1640 medium that was supplemented with 10% FBS
and incubated in the presence of each of the following
combinations: (1) GD3 ganglioside (10 or 20 mg/mL;
Matreya, Inc., PA, USA”; monoclonal anti-GD3 antibody R24
(10 or 20 mg/mL; Abcam Ltd., Cambridge, UK; (2) 0.2 U/mL
sialidase (N-6514; Sigma-Aldrich, USA) with or without
DANA (1 or 2 mM, Calbiochem); (3) 10 or 20 mg/mL GD3
ganglioside with or without 0.2 U/mL sialidase for 3.5 hours at
37C, followed by extensive washing with RPMI 1640
medium supplemented with 0.25% FBS and testing using
a cytotoxicity assay.
The HeLa cells were seeded at a concentration of 1  105
cells/well on 48-well plates and grown in 200 mL DMEM
supplemented with 10% FBS. The cells were treated with 0.2
U/mL sialidase, with or without 1 or 2 mM DANA, for 3.5
hours at 37C, followed by extensive washing with DMEM
medium supplemented with 0.25% FBS, then tested using
a flow assay to detect GD3 expression. The cells were then
washed twice with PBS and analyzed using a fluorescence
reader (Molecular Devices, Sunnyvale, CA, USA) at excitation
wavelengths ranging from 520e550 nm and an emission
wavelength of 580 nm [28e30].NK:Target R
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Fig. 1. Coculture with cervical cancer cell lines decreases the cytotoxicity of NK ce
HeLa (7) tumor cell lines, respectively. After 3.5 hours of coculturing, the NK c
release assay at the indicated NK:target ratio. (B) NK cells were cocultured with
a chromium release assay at an NK:target ratio of 1:1. Data are shown as the mea
viability of the NK cells was assessed by flow cytometry using FITC-labeled an
cocultured NK cells (white bar) was compared with NK cells alone (black bar). DStatistical analysisStatistical analysis was performed using the SPSS 17.0
software package (SPSS Science, Chicago, IL, USA). The
statistical significances of two groups were determined using
the unpaired t test, and more than two groups were analyzed
using one-way ANOVA followed by the post hoc t test with
the least significant difference (LSD) correction. Differences
between two conditions were considered statistically signifi-
cant at p< 0.05 (* p< 0.05; ** p< 0.01; *** p< 0.001).
ResultsReduced NK cell cytotoxicity when cocultured with
cervical cancer cell linesConsistent with a previous study [25], NK cells were isolated
from the PBMCs of healthy people and cocultured with various
kinds of cervical cancer cell lines (CC7T, CaSki, and HeLa
cells), followed byNK-mediated lysis using a chromium release
assay that used K562 cells as the target cells. As shown in
Fig. 1A significant decrease in the killing efficiency was
observed in the cocultured NK cells in comparison with NK
cells alone. NK cells that were cocultured with HeLa cells
showed the lowest cytotoxic activity compared with NK cellsatio
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cells that were cocultured with HeLa cells were used as the
experimental model for the following analyses (Fig. 1B). The
viability of the NK cells was comparable between NK cells that
were cultured alone and cocultured NK cells (Fig. 1C).Exogenous GD3 ganglioside and sialidase treatment
reduces the cytotoxic effects of NK cellsGD3 ganglioside, which has been reported as a possible
inhibitor of NK cell cytotoxicity, is expressed at tremendously
high levels in almost all melanoma tissues and cell lines
[9,10]. To examine whether NK cell cytotoxicity is inhibited
by exogenous GD3, NK cells were incubated with different
doses of GD3 and the GD3 antibody, by analysis using the
chromium release assay. After treatment with 10 or 20 mg/mL
GD3 ganglioside, NK cell cytotoxicity decreased in a dose-
dependent manner. The decreased cytotoxicity of the NK
cells was restored following treatment with GD3 plus the GD3
antibody (Fig. 2A). In addition to GD3 ganglioside, sialidase
treatment also reduced NK cell activities. Consistent with
a previous study [25], sialidase inhibitor (DANA) restored the
inhibition of NK cell cytotoxicity (Fig. 2B). When the NK
cells were cotreated with sialidase and GD3, sialidase
enhanced the suppression of NK cell cytotoxicity that was
caused by GD3 (Fig. 2C).B
NK
GD3
10 ug
/ml
GD3
20ug
/ml
GD3
10ug
/ml+S
ialida
se
GD3
20ug
/ml+S
ialida
se
Sp
ec
ific
 ly
sis
 (%
)
0
10
20
30
40
50
NK
GD3
10ug
/ml
GD3
20ug
/ml
GD3+
R24(10
ug/m
l)
GD3+
R24(20
ug/m
l)
Sp
ec
ific
 ly
sis
 (%
)
0
10
20
30
40
50
60
70
A
C 
Fig. 2. Exogenous GD3 or sialidase treatment reduces NK cell cytotoxicity (A) NK c
GD3 antibody (R24) (slash and horizontal line bar) in vitro. (B) NK cells were treate
(white and slash bar) in vitro. After 3.5 hours of treatment, the cells were assessed
NK:target ratio 1:1. The killing efficiency of the treated NK cells was compared w
(n¼ 3). (C) NK cells were treated with GD3 ganglioside alone (gray and white bar)
treatment, the cells were assessed for their ability to kill K562 target cells using aUpregulation of GD3 and sialidase in HeLa cells when
cocultured with NK cellsOur data show that exogenous GD3 and sialidase down-
regulate NK cell cytotoxicity; however, we would also like to
know whether GD3 and sialidase were induced by coculturing
the NK and HeLa cells. To determine this, cocultured HeLa
cells were stained with the FITC-labeled anti-human GD3
antibody. Flow cytometric analysis showed that the GD3
expression of the cocultured HeLa cells was approximately
1.8-fold higher than non-cocultured HeLa cells (Fig. 3A). Our
data suggest that the high GD3 expression level of the
cocultured HeLa cells could be a factor in the interaction
between HeLa and NK cells. As shown in Fig. 3B and 3C,
sialidase activity was also upregulated in the cocultured HeLa
cells, as well as in the cultured medium, after the HeLa and
NK cells were cocultured.Upregulation of GD3 in HeLa cells when treated with
sialidaseBased on the abovementioned findings, ganglioside plus
sialidase treatment can enhance the suppression of NK cell
cytotoxicity, so we tested whether ganglioside and sialidase
interact together by examining the effects of DANA. HeLa
cells that were cocultured with NK cells and incubated withNK
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Fig. 3. GD3 and sialidase are upregulated in HeLa cells after coculturing with NK cells (A) After coculturing with (white bar) or without NK cells (black bar), GD3
expression of the HeLa cells was detected by flow cytometry using FITC-labeled anti-GD3 antibody. Data are shown as the means SD (n¼ 5). (B) After
coculturing with (white bar) or without NK cells (black bar), the sialidase activity of the HeLa cells was detected as described in Materials and Methods section.
The values shown are relative to the control (HeLa cells plus PBS) and as the means SD (n¼ 4). (C) After coculturing with (white bar) or without NK cells
(black bar), the sialidase activity in the cultured medium was detected as described in Materials and Methods section.
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cytometer; BD Biosciences, United States) analysis in order to
observe any changes in GD3 expression. The data show that
DANA can significantly eliminate the high expression levels
of GD3 in cocultured HeLa cells (Fig. 4A). We also treated
HeLa cells with sialidase and DANA to study the effect of
GD3 expression of HeLa cells using FACS analysis. As shown
in Fig. 4B, the level of GD3 expression of the HeLa cells was
increased following sialidase treatment, as well as that of the
HeLa cells that were cocultured with NK cells, and thisB
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Fig. 4. GD3 expression is upregulated by sialidase and inhibited by DANA (A) HeL
(gray and white bar). After coculturing, the level of GD3 expression in the HeLa ce
Data are shown as means SD (n¼ 5). (B) HeLa cells were treated with sialidase
coculturing, the GD3 expression of the HeLa cells was detected by flow cytometr
(n¼ 3).increase could be recovered by DANA. These results sug-
gested that an interaction between GD3 and sialidase might be
involved in mediating NK cell activity during the coculturing
of HeLa and NK cells.
Discussion
It has been proposed that NK cell cytotoxicity is down-
regulated in patients with cervical carcinoma [7,8]. In this
study, we found that NK cells from healthy people also exhibitHeLa Sialid
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These results suggest that cervical cancer could possibly
escape the immune response by suppressing NK cell cyto-
toxicity. To investigate how cervical cancer interacts with NK
cells and restrains their cytotoxicity, we used HeLa cells as the
experimental model and cocultured HeLa cells with NK cells
to test our hypothesis.
We suppose that sialidase and GD3 act synergistically to
inhibit NK cell cytotoxicity. Although many studies have
addressed activated NK cell resistance to virus-infected and
tumor cells via a balance between inhibitory and activating
receptors, such as NKp30, NKp44, NKp46, and NKG2D
[31e33], GD3 and sialidase are less often reported in studies on
the interactions between NK cells and cancer cells. We followed
Nicoll’s study by treatingNKcellswith sialidase and then testing
the changes in the cytotoxicity of theNKcells [23].However, our
data show that NK cell cytotoxicity is directly inhibited by sia-
lidase treatment without interactions between siglec-7 and GD3.
These results differ from that of Nicoll, but are the same as those
reported byMoebius [24]. In addition to sialidase treatment, NK
cells incubated with GD3 showed decreased cytotoxic activities
as well. When NK cells were cotreated with GD3 plus sialidase,
suppression of NK cell cytotoxicity was evident. These results
indicate that sialidase and GD3 could act synergistically to
inhibit NK cell cytotoxicity.
GD3 is a glycosphingolipid that contains a2,8-linked dis-
ialic acids, and sialidase is an enzyme that can remove
terminal sialic acid residues from glycoproteins and glyco-
lipids. GD3 is the substrate of sialidase, however we observed
that both sialidase activity and GD3 expression were upregu-
lated in HeLa cells after coculturing with NK cells. Moreover,
sialidase treatment enhanced the level of GD3 expression in
HeLa cells, and the higher GD3 expression could be recovered
by the sialidase inhibitor, DANA. These data imply that after
coculturing with NK cells, HeLa cells can secrete sialidase in
order to increase GD3 expression, and then sialidase and GD3
act synergistically to inhibit NK cell cytotoxicity. This is
possibly a self-protection mechanism used by cervical cancer
to escape NK cell immunosurveillance.
The downregulated cytotoxicity of NK cells that was caused
by HeLa cells can be partially recovered by DANA treatment.
However, the inhibition of cytotoxicity in cocultured NK cells
could not be recovered to the level of the non-cocultured NK
cells by the use of DANA. These data indicate that there are
other factors involved in the interaction between NK and HeLa
cells. It has been reported that malignant cells could produce
soluble factors, such as immunosuppressive cytokines and
prostaglandins, in order to escape immune responses [34];
therefore, we evaluated the cytokines that were released by NK
and HeLa cells during coculturing using “the Human Cytokine
Protein Array 3.1 kit (AAH-CYT-3-4), an antibody-based array
(RayBiotech, Inc, Norcross, Ga), which could detect 42 cyto-
kines simultaneously, including epithelial neutrophil activating
peptide (ENA)-78, granulocyte colony-stimulating factor
(GCSF), granulocyte/macrophage colony-stimulating factor
(GM-CSF), growth regulated oncogene (GRO), growth regu-
lated oncogene-a (GRO-a), monokine-induced by interferon-g(MIG), interleukin (IL)-1a, IL-1b, IL-2, IL-3, IL-4, IL-5, IL-6,
IL-7, IL-8, IL-10, IL-12, IL-13, IL-15, interferon-gamma
(IFN-gamma), monocyte chemoattractant protein-1 (MCP-1),
MCP-2, MCP-3, macrophage colony-stimulating factor
(MCSF), macrophage-derived chemokine (MDC), monokine-
induced by interferon-g (MIG), macrophage inflammatory
protein-1d (MIP-1d), regulated upon activation, normal T-cell
expressed and secreted (RANTES), stem cell factor (SCF),
stromal cell derived factor-1 (SDF-1), thymus and activation-
regulated chemokine (TARC), transforming growth factor-b1
(TGF-b1), tumor necrosis factor (TNF)-a, TNF-b, epidermal
growth factor (EGF), insulin-like growth factor-I (IGF-I),
Angiogenin, Oncostatin M (OSM), Thrombopoietin, vascular
endothelial growth factor (VEGF)-A, platelet-derived growth
factor-b (PDGF-b), and leptin. We found that GRO, GRO-a,
MCP-1, IL-6, -8, -10, -13, and IFN-g were upregulated in the
cocultured medium (data not shown). The cultured medium of
NK cells and cocultured medium of NK and HeLa cells were
detected by human cytokine antibody array. Compared to the
cultured medium of NK cells (control), GRO, GRO-a, MCP-1,
IL-6, -8, -10, -13, and IFN-gamma were increased in the
cocultured medium of NK and HeLa cells. ELISA assays were
used to confirm the result of cytokine array. The data showed
that the cocultured medium of HeLa cells and NK cells from
different peoples might result in different increase levels of
IFN-gamma and IL-13. Furthermore, using the ELISA assay,
we found that IFN-g and IL-13 expression levels differed
between the NK cells of individual people, but IL-6, IL-8 and
IL-10 were comparable (data not shown). Based on these data,
we suggest that IFN-g and IL-13 are produced by NK cells
and IL-6, IL-8 and IL-10 might be secreted by tumor cells.
Among these cytokines, IL-6 (26-fold induction) and IL-10
(4.6-fold induction) might be the dominant cytokines
involved in mediating NK cell cytotoxicity because they are
believed to be present in the tumor microenvironment in order
to promote tumor growth and suppress immune responses
[35e38]. However, the manner in which these cytokines
mediate NK cell cytotoxicity during coculturing requires
further investigation.
Taken together, the interaction between cancer cells and
immune cells might be more complicated than the parameters
of our testing. However, based on our results, we have iden-
tified the important role played by both GD3 and sialidases in
the interaction between cervical cancer cell lines and NK cells,
specifically that both could inhibit the cytotoxic ability of NK
cells. These findings are worthy of further investigation.Acknowledgments
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